There is no overdose risk with the administration of the vaccine. Careful dosing, administration, and adherence to the vaccine guidelines should preclude any chance of overdosing. Preclinical studies demonstrated no toxicity in rats when the modified pneumococcal vaccine was administered subcutaneously three times in 2-weeks at a supratherapeutic dose.